Human atrium transcript analysis of permanent atrial fibrillation

International Heart Journal

Volumn 55, Issue 1, 2014, Pages 71-77

  Zhou, Jian ^a   Gao, Jie ^a   Liu, Yan ^a   Gu, Song ^a   Zhang, Xitao ^a   An, Xiangguang ^a   Yan, Jun ^a   Xin, Yue ^a   Su, Pixiong ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Inflammation; Metabolism; Remodeling; Transcriptome

Indexed keywords

ADULT; AGED; ATRIAL FIBRILLATION; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION PROFILING; HEART ATRIA; HUMANS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84893583749     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.13-196     Document Type: Article

References (36)

1. Curtis AB. Practice implications of the Atrial Fibrillation Guidelines. Am J Cardiol 2013; 111: 1660-70. (Review)
2. Magnani JW, Rienstra M, Lin H, et al. Atrial fibrillation: current knowledge and future directions in epidemiology and genomics. Circulation 2011; 124: 1982-93.
3. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995; 92: 1954-68.
4. Thijssen VL, Ausma J, Borgers M. Structural remodelling during chronic atrial fibrillation: act of programmed cell survival. Cardiovasc Res 2001; 52: 14-24. (Review)
5. Hoit BD, Shao Y, Gabel M, Walsh RA. Left atrial mechanical and biochemical adaptation to pacing induced heart failure. Cardiovasc Res 1995; 29: 469-74.
6. Casaclang-Verzosa G, Gersh BJ, Tsang TS. Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation. J Am Coll Cardiol 2008; 51: 1-11. (Review)
7. Vermeirssen V, Barrasa MI, Hidalgo CA, et al. Transcription factor modularity in a gene-centered C. elegans core neuronal protein- DNA interaction network. Genome Res 2007; 17: 1061-71.
8. Ohki R, Yamamoto K, Ueno S, et al. Gene expression profi ling of human atrial myocardium with atrial fibrillation by DNA microarray analysis. Int J Cardiol 2005; 102: 233-8.
9. Kim NH, Ahn Y, Oh SK, et al. Altered patterns of gene expression in response to chronic atrial fibrillation. Int Heart J 2005; 46: 383-95.
10. Barth AS, Merk S, Arnoldi E, et al. Reprogramming of the human atrial transcriptome in permanent atrial fibrillation: expression of a ventricular-like genomic signature. Circ Res 2005; 96: 1022-9.
11. Mayr M, Yusuf S, Weir G, et al. Combined metabolomic and proteomic analysis of human atrial fibrillation. J Am Coll Cardiol 2008; 51: 585-94.
12. Corradi D, Callegari S, Maestri R, et al. Heme oxygenase-1 expression in the left atrial myocardium of patients with chronic atrial fibrillation related to mitral valve disease: its regional relationship with structural remodeling. Hum Pathol 2008; 39: 1162-71.
13. Li JN, Zhao L, Wu J, et al. Differences in gene expression profi les and carcinogenesis pathways between colon and rectal cancer. J Dig Dis 2012; 13: 24-32.
14. Kaab S, Barth AS, Margerie D, et al. Global gene expression in human myocardium-oligonucleotide microarray analysis of regional diversity and transcriptional regulation in heart failure. J Mol Med 2004; 82: 308-16.
15. Poppelreuther M, Rudolph B, Du C, et al. The N-terminal region of acyl-CoA synthetase 3 is essential for both the localization on lipid droplets and the function in fatty acid uptake. J Lipid Res 2012; 53: 888-900.
16. Guo Y, Lip GY, Apostolakis S. inflammation in atrial fibrillation. J Am Coll Cardiol 2012; 60: 2263-70. (Review)
17. Marcus GM, Whooley MA, Glidden DV, Pawlikowska L, Zaroff JG, Olgin JE. Interleukin-6 and atrial fibrillation in patients with coronary artery disease: data from the Heart and Soul Study. Am Heart J 2008; 155: 303-9.
18. Pinto A, Tuttolomondo A, Casuccio A, et al. Immuno-infl ammatory predictors of stroke at follow-up in patients with chronic nonvalvular atrial fibrillation (NVAF). Clin Sci 2009; 116: 781-9.
19. Kaski JC, Arrebola-Moreno AL. inflammation and thrombosis in atrial fibrillation. Rev Esp Cardiol 2011; 64: 551-3. (Spanish)
20. Gu J, Liu X, Wang QX, et al. Angiotensin II increases CTGF expression via MAPKs/TGF-beta1/TRAF6 pathway in atrial fi broblasts. Exp Cell Res 2012; 318: 2105-15.
21. Anisimov SV, Tarasov KV, Riordon D, Wobus AM, Boheler KR. SAGE identification of differentiation responsive genes in P19 embryonic cells induced to form cardiomyocytes in vitro. Mech Dev 2002; 117: 25-74.
22. Wang Q, Maillard M, Schibler U, Burnier M, Gachon F. Cardiac hypertrophy, low blood pressure, and low aldosterone levels in mice devoid of the three circadian PAR bZip transcription factors DBP, HLF, and TEF. Am J Physiol Regul Integr Comp Physiol 2010; 299: R1013-9.
23. Di-Poi N, Koch U, Radtke F, Duboule D. Additive and global functions of HoxA cluster genes in mesoderm derivatives. Dev Biol 2010; 341: 488-98.
24. Adam O, Theobald K, Lavall D, et al. Increased lysyl oxidase expression and collagen cross-linking during atrial fibrillation. J Mol Cell Cardiol 2011; 50: 678-85.
25. Voigt N, Li N, Wang Q, et al. Enhanced sarcoplasmic reticulum Ca2+ leak and increased Na+-Ca2+ exchanger function underlie delayed afterdepolarizations in patients with chronic atrial fibrillation. Circulation 2012; 125: 2059-70.
26. Vargas LA, Alvarez BV. Carbonic anhydrase XIV in the normal and hypertrophic myocardium. J Mol Cell Cardiol 2012; 52: 741-52.
27. Garbers DL, Chrisman TD, Wiegn P, et al. Membrane guanylyl cyclase receptors: an update. Trends Endocrinol Metab 2006; 17: 251-8. (Review)
28. Cannone V, Boerrigter G, Cataliotti A, et al. A genetic variant of the atrial natriuretic peptide gene is associated with cardiometabolic protection in the general community. J Am Coll Cardiol 2011; 58: 629-36.
29. Patton KK, Ellinor PT, Heckbert SR, et al. N-terminal pro-B-type natriuretic peptide is a major predictor of the development of atrial fibrillation: the Cardiovascular Health Study. Circulation 2009; 120: 1768-74.
30. Lopaschuk GD, Jaswal JS. Energy metabolic phenotype of the cardiomyocyte during development, differentiation, and postnatal maturation. J Cardiovasc Pharmacol 2010; 56: 130-40. (Review)
31. Smetnev AS, Bunin Iu A, Nargizian AB, Petrovskii PF, Vakhliaev VD. Characteristics of lactate metabolism in the myocardium of patients with auricular fibrillation. Kardiologiia 1983; 23: 70-3. (Russian)
32. Barth AS, Kumordzie A, Frangakis C, Margulies KB, Cappola TP, Tomaselli GF. Reciprocal transcriptional regulation of metabolic and signaling pathways correlates with disease severity in heart failure. Circ Cardiovasc Genet 2011; 4: 475-83.
33. Jackson G, Atkinson L, Oram S. Improvement of myocardial metabolism in coronary arterial disease by beta-blockade. Br Heart Journal 1977; 39: 829-33.
34. Kim YM, Guzik TJ, Zhang YH, et al. A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation. Circ Res 2005; 97: 629-36.
35. Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 2000; 86: 494-501. (Review)
36. Mandal K, Torsney E, Poloniecki J, Camm AJ, Xu Q, Jahangiri M. Association of high intracellular, but not serum, heat shock protein 70 with postoperative atrial fibrillation. Ann Thorac Surg 2005; 79: 865-71.